Tpl2/Cot signals activate ERK, JNK, and NF-kappa B in a cell-type and stimulus-specific manner

Research output: Contribution to journalArticle


  • S Das
  • J Cho
  • I Lambertz
  • MA Kelliher
  • KY Du
  • PN Tsichlis


Macrophages and B-cells from Tpl2 knock-out mice exhibit a restricted defect in lipopolysaccharide and death receptor signaling that is limited to the activation of ERK. Here we show that Tpl2(-/-) MEFs exhibit defects in ERK, JNK, and NF-kappa B activation, or ERK activation only when stimulated with tumor necrosis factor-alpha (TNF-alpha) or interleukin-1 beta, respectively. In addition, we show that the activation of Tpl2 by TNF-alpha depends on signals transduced by both TRAF2 and RIP1. Activated Tpl2 phosphorylates MKK4/SEK1 upstream of JNK and stimulates NF-kappa B DNA binding and transcriptional activity by mechanisms that are independent of the nuclear translocation of p50 and p65. Tpl2-transduced TNF-alpha signals instead promote the phosphorylation of p65 at Ser(276) and modulate the spectrum of proteins associated with p65. Phosphorylation stimulates the transcriptional activity of NF-kappa B but does not affect its ability to bind DNA, which may be affected by the composition of the nuclear NF-kappa B complexes. These data confirm that defects caused by a single mutation may be cell-type and signal-specific and delineate the role of Tpl2 in the transduction of TNF-alpha signals that activate JNK and NF-kappa B in MEFs.


Original languageEnglish
Pages (from-to)23748-23757
Number of pages10
JournalJournal of Biological Chemistry
Issue number25
Publication statusPublished - 1 Jun 2005